Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with Ultra-Levura

被引：75

作者：

Perapoch, J

Planes, AM

Querol, A

López, V

Martínez-Bendayán, I

Tormo, R

Fernández, F

Peguero, G

Salcedo, S

机构：

[1] Hosp Maternoinfantil Vall Hebron, Serv Neonatol, Barcelona 08035, Spain

[2] Hosp Gen Valle Hebron, Microbiol Serv, Barcelona, Spain

[3] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2000年 / 19卷 / 06期

关键词：

D O I：

10.1007/s100960000295

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Ultra-Levura (Upsamedica, Spain) is a yeast (Saccharomyces boulardii) widely used as a biotherapeutic agent. To date, few adverse effects have been reported, although fungemia with Saccharomyces cerevisiae can occur in weak and immunosuppressed patients, Reported here are two cases of fungemia with Saccharomyces cerevisiae, One patient had been treated with Ultra-Levura and the other contracted the infection from the first, This is the first report of infection with Saccharomyces boulardii (Saccharomyces cerevisiae) in a patient who was not being treated with the agent.

引用

页码：468 / 470

页数：3

共 10 条

[1]

AVERY GB, 1968, PEDIATRICS, V41, P712

[2] Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii [J].